Trial Profile
A Study to investigate the Safety and Efficacy of Boceprevir or Telaprevir Containing Regimen Versus Pegylated Interferon/Ribavirin in Patients With Hepatitis C Virus (HCV) Infection
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Apr 2016
Price :
$35
*
At a glance
- Drugs Boceprevir (Primary) ; Telaprevir (Primary) ; Peginterferon; Ribavirin
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 12 Apr 2016 New trial record